Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5695765 | Gynecologic Oncology | 2017 | 7 Pages |
Abstract
In selected cases, a hysterectomy may be an effective means to either reduce or eliminate tumor bulk. Primary hysterectomy should mainly be considered in older patients with localized disease and no desire to preserve fertility, whereas patients with chemotherapy-resistant disease may benefit from additional hysterectomy, especially when disease is localized. For patients with widespread metastatic disease, the benefit of hysterectomy lies in the removal of chemotherapy-resistant tumor bulk with subsequent effect on survival.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Y.K. Eysbouts, L.F.A.G. Massuger, J. IntHout, C.A.R. Lok, F.C.G.J. Sweep, P.B. Ottevanger,